SCHEMBL30746493

SCHEMBL30746493

Cc1c(Cc2ccnc(Cl)n2)cncc1Nc1ccc(Cl)cc1F

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ NUDT1 P36639 3/20 0.43
▸ FLT1 P17948 8/20 0.38
▸ KDR P35968 8/20 0.38
▸ FGFR1 P11362 4/20 0.38
▸ TRPM5 Q9NZQ8 1/20 0.37
▸ EGFR P00533 3/20 0.36
▸ PDGFRB P09619 1/20 0.34
▸ EPHB2 P29323 1/20 0.34
▸ FLT4 P35916 1/20 0.34
▸ SLC6A2 P23975 1/20 0.33
▸ SLC6A4 P31645 1/20 0.33
▸ GPR52 Q9Y2T5 1/20 0.33
▸ TGFBR1 P36897 1/20 0.33
▸ ERBB2 P04626 1/20 0.33
▸ SRC P12931 1/20 0.33
▸ KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26985099 1.00 NUDT1 (0.43) NUDT1FLT1KDRFGFR1TRPM5
SCHEMBL26984973 0.89 NUDT1 (0.44) NUDT1FLT1KDRFGFR1TRPM5
SCHEMBL26985260 0.89 NUDT1 (0.42) NUDT1FLT1KDRFGFR1TRPM5
SCHEMBL30746523 0.89 NUDT1 (0.42) NUDT1FLT1KDRFGFR1TRPM5
SCHEMBL30746461 0.89 NUDT1 (0.44) NUDT1FLT1KDRFGFR1TRPM5
SCHEMBL26985111 0.83 NUDT1 (0.40) NUDT1FLT1KDRFGFR1GPR52
SCHEMBL30746584 0.83 NUDT1 (0.40) NUDT1FLT1KDRFGFR1GPR52
SCHEMBL26984868 0.81 NUDT1 (0.42) NUDT1FLT1KDRFGFR1TRPM5
SCHEMBL30746657 0.80 NUDT1 (0.45) NUDT1FLT1KDRFGFR1TRPM5
SCHEMBL26985076 0.80 NUDT1 (0.45) NUDT1FLT1KDRFGFR1TRPM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120129678-A Mitogen-activated protein kinase (MEK) inhibitors 耐斯泰德医疗公司 2025-06-10 — — CN disclosed
EP-4551558-A2 MITOGEN-ACTIVATED PROTEIN KINASE (MEK) INHIBITORS Nested Therapeutics, Inc. (US) 2025-05-14 — — EP disclosed
WO-2024010925-A2 MITOGEN-ACTIVATED PROTEIN KINASE (MEK) INHIBITORS NESTED THERAPEUTICS, INC. (US) 2024-01-11 — — WO disclosed
Send feedback